[Home] [Back] [Up] [<<] [>>]


Anticoagulant monitoring


Anticoagulant monitoring See also Thrombolytic therapy .
  Heparin (standard, unfractionated)  
    Prior to commencing therapy FBC , platelet count ; baseline APTT , INR if patient on warfarin; PT if warfarin treatment planned.
    During therapy Platelet counts 2-3 times weekly are recommended.
      Continuous IV infusion APTT ; check therapeutic interval with laboratory. In the first 24 hours, frequent assessment may be required, but the APTT should not be performed <4 hours after any change in dose. Subsequently, a daily APTT usually suffices.
      Intermittent IV injection Monitoring not of value.
      Prophylactic SC injection (low dose 
      heparin)
Monitoring not of value.
    If bleeding occurs APTT ; FBC , platelet count . Check other medications with patient and/or from records. Concomitant aspirin or other NSAID increase the risk of bleeding; their effect on platelet function is predictable and testing is not indicated. The possibility of a pre-existent acquired or inherited bleeding disorder should also be considered.
    If progression of thrombosis, or
    thrombosis in other site(s)
 
      Inadequate anticoagulation APTT .
      Heparin-induced thrombocytopenia
      (HIT type II)
FBC , platelet count ; heparin-dependent platelet antibodies if significant thrombocytopenia is documented.
      Antithrombin III deficiency Antithrombin III assay: should be deferred until heparin has been ceased. See under Thrombosis - venous.
  Low Molecular Weight Heparin (LMWH)   
  and heparinoids
The standard dose protocol is based on body weight; monitoring is not usually required except in renal failure or other high risk bleeding situations. Heparin-induced thrombocytopenia is less common than with standard, unfractionated heparin, but may occur: see above.
    Prophylactic SC injection Monitoring is not cost-effective and is not indicated.
    Continuous IV infusion (full dose,   
    therapeutic LMWH)
Anti Xa assay is the appropriate test, if testing is required; for therapeutic interval, consult pathologist.
  Oral anticoagulants INR .
    If bleeding occurs  
      Excessive anticoagulation INR .
        Alcohol  
        Diet  
        Intercurrent illness  
        Cardiac failure  
        Diarrhoea  
        Other drugs esp

Consult pathologist/pharmacist about drug interactions; consider possibility of recent change in dose, introduction of new, or non-prescribed, medications.
          Analgesics  
          Antibiotics  
          Aspirin, other NSAID Predictable effect on platelet function; bleeding time does not predict the risk of bleeding and is not indicated.
        Dose error  
      Concomitant bleeding disorder See Bleeding .





[Home] [Back] [Up] [<<] [>>]